RUBIN PAUL D
Known title: Chief Medical OfficerCIK: 0001210905
Associated companies
Transaction History
| BIOA | ▲ Buy | Option Exercise | 3,383 | $22K | 4/1/2026 | View on chart |
| BIOA | ▲ Buy | Option Exercise | 5,437 | $22K | 4/1/2026 | View on chart |
| BIOA | ▼ Sell | Open Market | 8,820 | $157K | 4/1/2026 | View on chart |
| BIOA | ▲ Buy | Option Exercise | 5,433 | $22K | 3/2/2026 | View on chart |
| BIOA | ▲ Buy | Option Exercise | 2,000 | $13K | 3/2/2026 | View on chart |
| BIOA | ▼ Sell | Open Market | 7,433 | $151K | 3/2/2026 | View on chart |
| BIOA | ▲ Buy | Option Exercise | 2,000 | $13K | 2/2/2026 | View on chart |
| BIOA | ▲ Buy | Option Exercise | 5,433 | $22K | 2/2/2026 | View on chart |
| BIOA | ▼ Sell | Open Market | 7,433 | $139K | 2/2/2026 | View on chart |
| BIOA | ▼ Sell | Open Market | 7,433 | $95K | 1/2/2026 | View on chart |
| BIOA | ▲ Buy | Option Exercise | 5,433 | $22K | 1/2/2026 | View on chart |
| BIOA | ▲ Buy | Option Exercise | 2,000 | $13K | 1/2/2026 | View on chart |
| BIOA | ▼ Sell | Open Market | 18,000 | $216K | 12/9/2025 | View on chart |
| BIOA | ▲ Buy | Option Exercise | 18,000 | $118K | 12/9/2025 | View on chart |
| BIOA | ▲ Buy | Option Exercise | 68,897 | $283K | 12/4/2025 | View on chart |
| BIOA | ▼ Sell | Open Market | 68,897 | $702K | 12/4/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
BioAge Labs to Present at Investor Conferences
BioAge Labs announced it will present at upcoming investor conferences, providing a platform to share company updates with the market. The stock is currently trading near its 52-week low, which may increase attention from investors seeking value. This corporate activity adds context to the recent whale alerts noted in healthcare stocks.
BioAge Labs to Present at Investor Conferences. BioAge Labs announced it will present at upcoming investor conferences, providing a platform to share company updates with the market. The stock is currently trading near its 52-week low, which may increase attention from investors seeking value. This corporate activity adds context to the recent whale alerts noted in healthcare stocks.